Now is the time to address the Culture of Residential Aged Care Facilities to support Pharmacists in reducing psychotropic prescribing

Mouna Sawan (Corresponding Author), Timothy Chen, Phyo Kyaw Myint, Yun-Hee Jeon, Sarah Hilmer

Research output: Contribution to journalEditorial


The high‐level use of psychotropic medicines, particularly antipsychotics, for the treatment of behavioural and psychological symptoms of dementia (BPSD) in residential aged care facilities (RACFs) is widely reported. The current estimates of the prevalence of psychotropic medicines in such facilities are high: 44% in the UK,1 61% in Australia2 and over 60% in the United States.3 Psychotropic medicines are recommended not to be used first‐line for the management of BPSD, and among residents with dementia are associated with significant adverse outcomes.3, 4 However, the use of these medicines remains high. They are often used outside of approved indications, for longer than recommended or at higher doses.
Original languageEnglish
Pages (from-to)404-405
Number of pages2
JournalInternational Journal of Pharmacy Practice
Issue number5
Early online date6 Sep 2019
Publication statusPublished - Oct 2019


Cite this